The stock price of Teladoc Health Inc (NYSE: TDOC) has dropped by -1.62 compared to previous close of 12.99. Despite this, the company has seen a fall of -1.77% in its stock price over the last five trading days. InvestorPlace reported 2024-05-02 that For a time, Cathie Wood was the hottest investor on Wall Street. Ark Invest was bringing in billions of dollars in new assets under management.
Is It Worth Investing in Teladoc Health Inc (NYSE: TDOC) Right Now?
Company’s 36-month beta value is 1.02.Analysts have differing opinions on the stock, with 6 analysts rating it as a “buy,” 4 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for TDOC is 167.74M, and currently, short sellers hold a 15.98% ratio of that floaft. The average trading volume of TDOC on May 06, 2024 was 5.23M shares.
TDOC’s Market Performance
TDOC’s stock has seen a -1.77% decrease for the week, with a -10.32% drop in the past month and a -35.42% fall in the past quarter. The volatility ratio for the week is 4.86%, and the volatility levels for the past 30 days are at 4.26% for Teladoc Health Inc The simple moving average for the last 20 days is -6.21% for TDOC’s stock, with a simple moving average of -32.76% for the last 200 days.
Analysts’ Opinion of TDOC
Many brokerage firms have already submitted their reports for TDOC stocks, with Cantor Fitzgerald repeating the rating for TDOC by listing it as a “Overweight.” The predicted price for TDOC in the upcoming period, according to Cantor Fitzgerald is $22 based on the research report published on February 29, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see TDOC reach a price target of $17. The rating they have provided for TDOC stocks is “Market Perform” according to the report published on February 26th, 2024.
DA Davidson gave a rating of “Neutral” to TDOC, setting the target price at $22 in the report published on January 17th of the current year.
TDOC Trading at -11.50% from the 50-Day Moving Average
After a stumble in the market that brought TDOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.97% of loss for the given period.
Volatility was left at 4.26%, however, over the last 30 days, the volatility rate increased by 4.86%, as shares sank -11.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -15.98% lower at present.
During the last 5 trading sessions, TDOC fell by -1.77%, which changed the moving average for the period of 200-days by -49.41% in comparison to the 20-day moving average, which settled at $13.54. In addition, Teladoc Health Inc saw -40.70% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TDOC starting from Kornwasser Laizer, who sale 10,411 shares at the price of $12.69 back on May 02 ’24. After this action, Kornwasser Laizer now owns 86,070 shares of Teladoc Health Inc, valued at $132,095 using the latest closing price.
Waters Michael Willem, the CHIEF OPERATING OFFICER of Teladoc Health Inc, sale 5,793 shares at $12.69 during a trade that took place back on May 02 ’24, which means that Waters Michael Willem is holding 64,881 shares at $73,502 based on the most recent closing price.
Stock Fundamentals for TDOC
Current profitability levels for the company are sitting at:
- -0.11 for the present operating margin
- 0.67 for the gross margin
The net margin for Teladoc Health Inc stands at -0.09. The total capital return value is set at -0.07. Equity return is now at value -10.18, with -5.40 for asset returns.
Based on Teladoc Health Inc (TDOC), the company’s capital structure generated 0.4 points at debt to capital in total, while cash flow to debt ratio is standing at 0.22. The debt to equity ratio resting at 0.68. The interest coverage ratio of the stock is -8.76.
Currently, EBITDA for the company is 192.05 million with net debt to EBITDA at -3.03. When we switch over and look at the enterprise to sales, we see a ratio of 1.02. The receivables turnover for the company is 11.5for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.73.
Conclusion
In a nutshell, Teladoc Health Inc (TDOC) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
